Interesting developments with an interesting and highly prospective product, but I think the SP will slide back a few points over the next few days - yesterdays announcement shows that things are all progressing well but at the end of the day it was only an arrangement to produce their product for the purposes of the trials, under commercial conditions.
I think approval of this product after the UK trial (which will automatically mean it is approved for the EU) will be the big SP driving announcement.
Surely management must be working on getting an FDA trial underway as well.
Looking for a 19 - 20 cent entry point.
Add to My Watchlist
What is My Watchlist?